Introduction

Pharmaceutical manufacturing is at a turning point. The pressure to increase efficiency, ensure compliance and improve operational visibility has never been higher. Yet, despite years of investment in digital initiatives, many organizations still rely heavily on paper-based processes and fragmented systems.

The challenge is not a lack of technology. It´s the way digitalization is approached.

Traditional implementation models, often centered around large-scale systems, are slow, complex and risky. They require significant upfront investment and long delivery timelines before any value is realized. In a fast-evolving environment, this approach is increasingly misaligned with business needs.

A new model is emerging that prioritizes speed, adaptability and incremental value delivery.

By leveraging platforms like Tulip, Pharma organizations can adopt a phased approach Explore, Scale and Transform. This model enables teams to start small, validate quickly and expand progressively. Reducing risk while accelerating impact.